Effects of SKF-10047 (cas 133005-41-1) in the phencyclidine-dependent rat: Evidence for common receptor mechanisms☆

Add time:08/30/2019    Source:sciencedirect.com

The repeated administration of phencyclidine (PCP, 72 mg/kg/day) to rats led to physical dependence, as evidenced by a withdrawal syndrome exhibited approx. 24–48 h following suspension of drug. All components of the withdrawal syndrome were suppressed by s.c. injections of PCP (16 mg/kg), (±)-N-allylnormetazocine (SKF-10047 (cas 133005-41-1), 16 mg/kg) and (+)-SKF-10047 (16 mg/kg), but not by injections of saline or (−)-SKF-10047. Moreover, tolerance to the behavioral effects of PCP, as well as cross-tolerance to (±)-SKF-10047 and (+)-SKF-10047 were observed. These data indicate that PCP and the sigma opiate SKF-10047 share mechanisms of action, which are mediated by the (+)-isomer of the sigma agonist.

We also recommend Trading Suppliers and Manufacturers of SKF-10047 (cas 133005-41-1). Pls Click Website Link as below: cas 133005-41-1 suppliers

Prev:Full PaperSKF-10047 (cas 133005-41-1), a prototype Sigma-1 receptor agonist, augmented the membrane trafficking and uptake activity of the serotonin transporter and its C-terminus-deleted mutant via a Sigma-1 receptor-independent mechanism
Next:Rapid communicationIP3 receptor antagonist heparin uncompetitively inhibits [3H](+)-SKF-10047 (cas 133005-41-1) binding to σ receptors)